𝔖 Bobbio Scriptorium
✦   LIBER   ✦

543 EARLY HEPATITIS B IMMUNOGLOBULIN WITHDRAWAL AND MAINTENANCE NUCLEOS(T)IDE ANALOGUES FOR THE PREVENTION OF HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION

✍ Scribed by I.W. Graziadei; H. Zoller; S. Schneeberger; J. Pratschke; W. Vogel

Book ID
117379688
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
40 KB
Volume
54
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis B immunoglobulin and/or nucleo
Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review
✍ Evangelos Cholongitas; John Goulis; Evangelos Akriviadis; Geore V. Papatheodorid πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 395 KB

A combination of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NUCs) is currently recommended as prophylaxis against the recurrence of hepatitis B virus (HBV) after liver transplantation (LT), but the optimal protocol is a matter of controversy. The aim of this study was the identif

Low risk of hepatitis B virus recurrence
Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy
✍ Stephen N. Wong; Chi-Jen Chu; Chun-Tao Wai; Terese Howell; Charles Moore; Robert πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 103 KB

Hepatitis B virus (HBV) recurrence rates of 0-16% had been reported in patients maintained on nucleoside analogues (NA) after hepatitis B immunoglobulin (HBIG) discontinuation after orthotopic liver transplantation (OLT). However, follow-up in most studies was short. We aimed to determine the long-t